FDA marketing authorizations for AI-powered medical tools have passed 1,500, with oncology among the fastest-growing categories.
A record number of AI devices qualified this year for Medicare's temporary new technology add-on payments, STAT reports.
Korea's Roen Surgical won FDA 510(k) clearance for Zamenix, an AI-guided flexible ureteroscope robot for kidney stone surgery.